Researchers
Popović, Maja
Type
Date issued
Results 1-9 of 9
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Immunotherapy maintenance versus immunotherapy after progression on platinum-based chemotherapy in the treatment of locally advanced or metastatic urothelial cancer![]() | Popovic, Lazar | Conference Paper | Mp. category will be shown later |
| 2025 | Comparation between treatment outcomes among patients with diffuse-large B-cell lymphoma treated between 2003-2010 and 2017-2021 treated with rituximab-based immunochemotherapy![]() | Đurić, Stefan; Popovic, Maja | Conference Paper | Mp. category will be shown later |
| 2025 | First experience with antibody-drug conjugates trastuzumab deruxtecan and sacituzumab-govitecan in heavily pretreated patients with metastatic breast cancer![]() | Popovic, Lazar | Conference Paper | Mp. category will be shown later |
| 2025 | Second line treatment of clear cell renal cell carcinoma after progression on a tyrosine kinase inhibitor![]() | Popovic, Maja | Conference Paper | Mp. category will be shown later |
| 2024 | Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review![]() | Cvetanovic, Ana S | Article | 21M21 |
| 2024 | Follicular lymphoma and chronic lymphocytic leukemia, 10 years, single institution![]() | Nikin, Zoran; Ivkovic-Kapic, Tatjana | Conference Paper | Mp. category will be shown later |
| 2023 | Targeting triple-negative breast cancer: A clinical perspective![]() | Popovic, Lazar S | Article | 21M21 |
| 2022 | Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma![]() | Popovic, Maja | Article | 22M22 |
| 2021 | Immunotherapy in the treatment of lymphoma![]() | Popovic, Lazar S | Article | 22M22 |
